Showing results (1-10 of 291) with videos related to
Sort By:
Pageof 30
Seminars in Cancer Biology|November 5, 1999
DNA methylation and the Epstein-Barr virusR F Ambinder, K D Robertson, Q TaoBlood|March 7, 1998
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissueQ Tao, K D Robertson, A Manns, et al.Journal of Virology|August 8, 1998
The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveQ Tao, K D Robertson, A Manns, et al.Journal of Virology|September 1, 1997
Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoterK D Robertson, R F AmbinderBlood|December 31, 1997
Methylation of the Epstein-Barr virus genome in normal lymphocytesK D Robertson, R F AmbinderThe American Journal of Pathology|August 6, 1999
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysisQ Tao, L J Swinnen, J Yang, et al.Seminars in Cancer Biology|August 1, 1996
Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinomaR F Ambinder, K D Robertson, S M Moore, et al.Molecular and Cellular Biology|November 1, 1995
Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucialK D Robertson, S D Hayward, P D Ling, et al.Blood|October 15, 1996
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's diseaseK D Robertson, A Manns, L J Swinnen, et al.Bone Marrow Transplantation|May 19, 2009
The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infectionR F AmbinderPageof 30